Category Archives: MS Treatment

NEW YORK, June 24, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced a new clinical program focused on the development of NurOwn® as a treatment for Alzheimer's disease. As part of the newly announced program, the Company is planning a multi-national Phase 2 clinical trial to evaluate the safety and efficacy of NurOwn treatment in patients with prodromal to mild Alzheimer's disease Continue reading →

Officially, she calls herself Juliana, but she also goes by the name Anna Morena and has an organization of the same namethe Anna Foundation Uganda. Continue reading →

New York Citys the best marathon I think there is, she said. I ran Chicago, but it just didnt compare. Updated June 24, 2020 A commentary published this month on the website of the British Journal of Sports Medicine points out that covering your face during exercise comes with issues of potential breathing restriction and discomfort and requires balancing benefits versus possible adverse events Continue reading →

Aminat Lorsanova tried to run away from home five times before she finally made it. Away from the family she said had abused her physically and psychologically since she was a child. Away from Chechnya, where women like her are supposed not to exist Continue reading →

Read Time: Researchers at Kessler Foundation conducted a comprehensive review of pharmacologic agents used in the treatment of multiple sclerosis, seeking evidence for efficacy for the cognitive dysfunction experienced by more than half of affected individuals. Continue reading →

Researchers Present Case Studies on Teriflunomide Therapy in Patients with COVID-19, Multiple Sclerosis Our observations in these 5 patients suggest that teriflunomide may not need to be discontinued in patients with MS who develop an active COVID-19 infection, said corresponding author Rohit Bakshi, MD, in a statement.2 Teriflunomide is an immunomodulating drug commonly used to treat MS, which often requires long-term therapy. The drug modulates the immune response by selectively reducing the level of activated T and B lymphocytes without suppressing the full immune response.1 The ongoing international, multicenter study is examining 5 patients ranging in age from 52 to 79 years, all of whom have been taking teriflunomide for at least 5 months.1 All of the patients continued taking teriflunomide after their COVID-19 diagnosis and had self-limiting illness without experiencing a relapse of their MS.1 The authors posited that teriflunomide could prevent an excessive immune response while still maintaining enough defense against the virus. They also noted that patients with MS who were treated with teriflunomide generally also developed effective immunity to seasonal influenza and rabies after the vaccinations, which could be an important thing to note when looking to the future of a COVID-19 vaccine.1 The investigators did note that their case series was small, retrospective, open-label, uncontrolled, and non-randomized, so more studies are necessary in order to confirm and extend their preliminary findings.1 A delicate balance may be necessary in the host immune response to successfully confront COVID-19 infection, Bakshi said. Continue reading →

Since most people in the U.S. Continue reading →

The global Primary Progressive Multiple Sclerosis Treatment Market report by wide-ranging study of the Primary Progressive Multiple Sclerosis Treatment industry which covers comprehensively all aspects of the different industry verticals. Continue reading →

Los Angeles, United State: Complete study of the global Primary Progressive Multiple Sclerosis Treatment market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Primary Progressive Multiple Sclerosis Treatment industry. Research techniques like PESTLE and Porters Five Forces analysis have been deployed by the researchers Continue reading →

Innovative Medicines Canada president Pamela Fralick, seen here on June 16, 2020, in Ottawa, says she's 'never seen the collaboration thats happening around this pandemic between governments and academics, philanthropists and industry.' Dave Chan/The Globe and Mail When most people think of Canadian medical innovation, the first thing that typically comes to mind is insulin. And while Banting and Bests discovery was a breakthrough in the treatment of diabetes, it also took place almost a century ago. We always go there, dont we? Continue reading →